CVR 40638350Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)HerlevFounded 4 Jul 2019
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Metaceutic ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, Aug 2026
-3 (-75%) over 12 months
Result
+2.4M
DKK, annual report 2025
Equity
276.8K
DKK, annual report 2025
A. Kazemi ApSCVR 40626263, 66.7% to under 90% of capital and votes
Ginnerup Capital ApSCVR 27463843, 5% to under 10% of capital and votes
Operating company
Dandex estimate: 1 employee registered in 2026Ali Kazemi Sereshtsince 4 Jul 2019
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 274638435% to under 10% of capital and votessince 17 May 2021
CVR 4062626366.7% to under 90% of capital and votessince 17 May 2021
CVR 40628843100% of capital and votes4 Jul 2019 to 15 Jun 2021
Ultimate controller
Holding in A. Kazemi ApS, since 1 Jul 2019
Holding company
CVR 40626263Private limited company (ApS)
Holding in Metaceutic ApS, since 17 May 2021
This company
Metaceutic ApS
CVR 40638350
1 Danish company.
SubsidiaryCVR 44861429100% of capital and votes
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR. Subsidiary (datterselskab): 50% or more of the votes, a Dandex estimate; in the 50% band a joint venture is not ruled out.
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 4 | 3 | 4 | 3 | 5 | 5 | 4 | 4 | 3 | 6 | 4 | 4 | 3 | 2 | 2 | 4 | 5 | 6 | 6 | 6 | 5 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 2 | 3 | 2 | 3 | 3 | 4 | 5 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit not reported, Operating profit 44.2K, Result for the year 2.4M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 2.4M, Equity 276.8K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -2,189 | -987 | -1,183 | -48 | Not reported |
| Operating profit | -4,192 | -1,777 | -1,961 | -1,096 | +44 |
| Result for the year | -4,186 | -1,802 | -2,037 | -1,319 | +2,365 |
| Equity | 2,066 | 1,268 | -769 | -2,088 | 277 |
| Total assets | 2,496 | 1,760 | 1,063 | 954 | 2,442 |
| Employees (average) | 4 | 2 | 1 | 2 | 2 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | -50% | -50% | 100% | Not reportednote 2 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Metaceutic ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 1,001,136, cash price 72.02, implied value 148,850,614 | 72.02 | 1,001,136 | 148,850,614 | 2,066,675 | |
| IncreaseCashPaid in 247,500, cash price 123.75, implied value 254,030,906 | 123.75 | 247,500 | 254,030,906 | 2,052,775 | |
| IncreaseCashPaid in 495,000, cash price 247.50, implied value 507,566,813 | 247.50 | 495,000 | 507,566,813 | 2,050,775 | |
| IncreaseCashPaid in 1,074,375, cash price 122.44, implied value 250,843,611 | 122.44 | 1,074,375 | 250,843,611 | 2,048,775 | |
| IncreaseDebt conversionPaid in 2,000,000 | None | 2,000,000 | None | 2,040,000 | |
| FoundingCashPaid in 46,920, cash price 1.17 | 1.17 | 46,920 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the continuing company (fortsættende selskab)
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
20 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Ny adresse: Lyskær 8B, 2., 2730 Herlev
Ny kommune: Herlev
Vedtægter ændret: 11.02.2026
Ny adresse: Mileparken 22, 2., 2740 Skovlunde
Ny kommune: Ballerup
Vedtægter ændret: 19.06.2024
Bestyrelse:
Fratrådte:
Kim Erik Ginnerup, den 19.06.2024, Jan Greve, (formand), den 19.06.2024, Ali Kazemi Seresht, den 19.06.2024.
Formål ændret: Selskabets formål er anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik.
Vedtægter ændret: 29.05.2024
Slettet binavn: Premind ApS
Ny adresse: Vandtårnsvej 62A, 2860 Søborg
Bestyrelse:
Fratrådte:
Jakob Saabye-Brøndum, den 22.06.2023.
Vedtægter ændret: 08.06.2022
Kapitalforhøjelsen er besluttet den 08.06.2022.
kr. 13.900,00, indbetalt kontant, kurs 7.202,42.
Kapitalen udgør herefter kr. 2.066.675,00.
Vedtægter ændret: 04.05.2022
Kapitalforhøjelsen er besluttet den 04.05.2022.
kr. 2.000,00, indbetalt kontant, kurs 12.375,00.
Kapitalen udgør herefter kr. 2.052.775,00.
Vedtægter ændret: 05.11.2021
Kapitalforhøjelsen er besluttet den 05.11.2021.
kr. 2.000,00, indbetalt kontant, kurs 24.750,00.
Kapitalen udgør herefter kr. 2.050.775,00.
Vedtægter ændret: 24.06.2021
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 40628843 Meta Corporation ApS, der samtidigt er opløst.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 40638350 Metaceutic ApS (fortsættende), der tillige driver virksomhed under navnene Premind ApS og CVR-nummer: 40628843 Meta Corporation ApS (ophørende).
Kapitalejerne i CVR-nummer: 40638350 Metaceutic ApS og CVR-nummer: 40628843 Meta Corporation ApS har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
Vedtægter ændret: 17.03.2021
Nyt binavn: Premind ApS
Vedtægter ændret: 22.01.2021
Kapitalforhøjelsen er besluttet den 22.01.2021.
kr. 1.025,00, indbetalt kontant, kurs 11.250,00. kr. 7.750,00, indbetalt kontant, kurs 12.375,00.
Kapitalen udgør herefter kr. 2.048.775,00.
Kapitalen er opdelt i klasser.
Vedtægter ændret: 30.12.2020
Kapitalforhøjelsen er besluttet den 30.12.2020.
kr. 2.000.000,00, indbetalt ved konvertering af gæld, kurs 100,00.
Kapitalen udgør herefter kr. 2.040.000,00.
Ny adresse: Vandtårnsvej 77, 2860 Søborg
Ny kommune: Gladsaxe
Bestyrelse:
Fratrådte:
Maria Maibøl Jakobsen, den 18.06.2020, Ali Kazemi Seresht, (formand), den 18.06.2020.
Tiltrådte:
Kim Erik Ginnerup, den 18.06.2020, Jan Greve, (formand), den 18.06.2020, Ali Kazemi Seresht, den 18.06.2020.
Ny adresse: Frederiksborgvej 399, Himmelev, 4000 Roskilde
Ny kommune: Roskilde
Stiftelsesdato: 04.07.2019.
Virkningsdato: 04.07.2019.
Seneste vedtægtsdato: 04.07.2019.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 117,30, fuldt indbetalt.
Stifter:
CVR-NR. 40628843 Meta Corporation ApS, Fruebjergvej 3, 2100 København Ø, den 04.07.2019.
Bestyrelse:
Ali Kazemi Seresht, (formand), den 04.07.2019, Maria Maibøl Jakobsen, den 04.07.2019, Jakob Saabye-Brøndum, den 04.07.2019.
Direktion:
Ali Kazemi Seresht, den 04.07.2019.
Selskabet tegnes af en direktør..
Første regnskabsår:
04.07.2019 - 31.12.2020.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er udvikling og salg af naturprodukter.
P-number 1024846993Lyskær 8, 2730 Herlev
P-number 1025942422Frederiksborgvej 399, 4000 Roskilde